We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

5401:TSENIPPON STEEL CORP. Analysis

Data as of 2026-03-11 - not real-time

¥612.60

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The stock is trading below its 20‑day and 50‑day moving averages, with an RSI in the low 40s and a bearish MACD histogram, indicating short‑term downside pressure. Volume has been stable and volatility remains elevated, while price sits near a key support level and well below the identified resistance.
Fundamental backdrop: Revenue is expanding at a solid pace, yet margins are thin and the company posted a negative profit margin, with operating cash flow and free cash flow effectively flat. The balance sheet is heavily leveraged, featuring an extremely high debt‑to‑equity ratio and cash reserves that cover only a fraction of total debt. Despite these challenges, the dividend yield sits around four percent with a payout ratio below fifty percent, and analysts maintain a buy consensus, projecting upside potential of roughly sixteen percent.
Valuation & outlook: A forward P/E near one and a price‑to‑book below one suggest the equity is priced attractively relative to its book value, but the debt burden and earnings weakness temper the case. Given the mix of growth in top‑line sales and value‑style pricing metrics, the stock appears undervalued but carries notable risk. Investors should weigh the immediate technical weakness against the longer‑term upside implied by earnings improvement and dividend appeal.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • price below short‑term moving averages
  • bearish MACD histogram
  • proximity to key support level

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • strong revenue growth trajectory
  • low forward price‑to‑earnings multiple
  • analyst consensus buy with modest upside target

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • potential operational restructuring to improve profitability
  • attractive dividend yield relative to peers
  • undervalued valuation metrics offering upside if earnings recover

Key Metrics & Analysis

Financial Health

Revenue Growth20.60%
Profit Margin-0.60%
P/E Ratio1.1
ROE-0.41%
ROA2.05%
Debt/Equity89.93
P/B Ratio0.6

Technical Analysis

TrendNeutral
RSI42.0
Support¥578.00
Resistance¥699.80
MA 20¥642.25
MA 50¥650.13
MA 200¥613.42
MACDBearish
VolumeStable
Fear & Greed Index76.91

Valuation

Target Price¥714.44
Upside/Downside16.62%
GradeUndervalued
TypeBlend
Dividend Yield4.00%

Risk Assessment

Beta0.36
Volatility37.71%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.